Key facts
- Notable investors include Hefei Innovation Technology Venture Capital, Hefei XingTai Capital Management, Changxing Fund, USTC Silicon Valley, Guoyuan Innovating Investment — 8 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 8 names
- ·Watchlist + deal alerts for Hechen Bioworkx
- ·The full record, as it builds
Funding rounds
No funding rounds for Hechen Bioworkx are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Hechen Bioworkx
Developer of functional active raw materials designed for the biology field. The company offers active raw materials, including functional nutrients and bioactive components, that are produced by combining rational metabolic modification and irrational evolutionary engineering, enabling high-efficiency engineered bacteria in the fields of cosmetics, food and beverage, health products, and animal and plant protection.
- Sector
- Healthcare
- HQ
- Hefei, China
- Founded
- 2022
- Employees
- 18
- Website
- hcbioworkx.com/
- Ownership
- Privately Held (backing)
Hechen Bioworkx doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Hechen Bioworkx shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Hechen Bioworkx in its N-PORT filings yet. We sweep new filings monthly.